|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: new caseFrom: Garry E. Siegel (garrys@mindspring.ocm)Wed May 31 21:09:11 2000
My >recommendation would be to use IUPCs in obese patients or in patients >without apparent uterine activity after receiving one or modre doses of >PGE1 (unless you are 100% convinced that the patient is not experiencing >uterine activity). > >LSR Thanks; in the patients in whom you aren't able or wish to AROM, would you just place an IUPC (I've not ever done that), or not place another dose since you can't be assured of the nature of the uterine activity? If you don't place a dose, do you then wait some time period (how long) to then reassess, or re-dose, or try to AROM, or start pitocin? Garry
-- Garry E. Siegel, M.D., F.A.C.O.G. Private Practice Roswell, GA
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 04:46:30 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.